Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade C 69.96 0.16% 0.11
ABBV closed up 0.16 percent on Friday, August 18, 2017, on 78 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ABBV trend table...

Date Alert Name Type % Chg
Aug 18 Stochastic Reached Oversold Other 0.00%
Aug 14 50 DMA Resistance Bearish -1.21%
Aug 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.21%
Aug 11 NR7 Range Contraction -0.95%
Aug 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.95%

Older signals for ABBV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 75.04
52 Week Low 54.0319
Average Volume 5,139,281
200-Day Moving Average 64.5355
50-Day Moving Average 71.3478
20-Day Moving Average 71.067
10-Day Moving Average 70.717
Average True Range 0.9834
ADX 18.09
+DI 16.26
-DI: 23.88
Chandelier Exit (Long, 3 ATRs) 72.0898
Chandelier Exit (Short, 3 ATRs) 72.3302
Upper Bollinger Band 73.1011
Lower Bollinger Band 69.0329
Percent B (%b) 0.23
Bandwidth 0.057245
MACD Line -0.3295
MACD Signal Line -0.1395
MACD Histogram -0.19